UP Strategic Wealth Investment Advisors LLC Sells 137 Shares of Cencora, Inc. (NYSE:COR)

UP Strategic Wealth Investment Advisors LLC decreased its position in Cencora, Inc. (NYSE:COR) by 9.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,315 shares of the company’s stock after selling 137 shares during the period. UP Strategic Wealth Investment Advisors LLC’s holdings in Cencora were worth $295,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in COR. Passumpsic Savings Bank raised its position in shares of Cencora by 4.9% during the third quarter. Passumpsic Savings Bank now owns 6,464 shares of the company’s stock worth $1,455,000 after purchasing an additional 304 shares during the period. Virtu Financial LLC lifted its stake in Cencora by 112.2% in the third quarter. Virtu Financial LLC now owns 10,227 shares of the company’s stock valued at $2,302,000 after buying an additional 5,407 shares in the last quarter. World Investment Advisors LLC acquired a new position in shares of Cencora in the third quarter valued at approximately $4,072,000. Arvest Bank Trust Division bought a new stake in shares of Cencora during the third quarter worth $218,000. Finally, Wilmington Savings Fund Society FSB bought a new stake in Cencora in the 3rd quarter valued at $566,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

Insider Transactions at Cencora

In related news, Chairman Steven H. Collis sold 14,579 shares of the firm’s stock in a transaction dated Tuesday, April 22nd. The stock was sold at an average price of $281.81, for a total value of $4,108,507.99. Following the sale, the chairman now directly owns 315,913 shares of the company’s stock, valued at $89,027,442.53. This trade represents a 4.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Elizabeth S. Campbell sold 4,127 shares of the business’s stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $268.28, for a total value of $1,107,191.56. Following the transaction, the executive vice president now directly owns 14,665 shares of the company’s stock, valued at approximately $3,934,326.20. The trade was a 21.96 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,223 shares of company stock valued at $13,580,967. 10.80% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms have issued reports on COR. Morgan Stanley set a $288.00 price target on Cencora in a research note on Tuesday, April 15th. StockNews.com raised Cencora from a “hold” rating to a “buy” rating in a research report on Wednesday, March 12th. Evercore ISI increased their target price on shares of Cencora from $270.00 to $280.00 and gave the stock an “outperform” rating in a report on Thursday, February 6th. Bank of America raised their price objective on Cencora from $270.00 to $285.00 and gave the company a “neutral” rating in a report on Friday, April 11th. Finally, Wells Fargo & Company boosted their price target on Cencora from $251.00 to $274.00 and gave the stock an “equal weight” rating in a research report on Friday, March 14th. Two equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $284.55.

Cencora Price Performance

Cencora stock opened at $281.89 on Friday. The stock’s 50 day moving average is $267.20 and its 200-day moving average is $248.71. The company has a market capitalization of $54.66 billion, a price-to-earnings ratio of 40.10, a PEG ratio of 1.31 and a beta of 0.55. Cencora, Inc. has a 12 month low of $214.77 and a 12 month high of $296.65. The company has a current ratio of 0.92, a quick ratio of 0.54 and a debt-to-equity ratio of 16.40.

Cencora (NYSE:COR) last released its quarterly earnings results on Wednesday, February 5th. The company reported $3.73 EPS for the quarter, beating the consensus estimate of $3.50 by $0.23. Cencora had a net margin of 0.46% and a return on equity of 328.62%. Equities research analysts expect that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Friday, February 14th were issued a $0.55 dividend. The ex-dividend date was Friday, February 14th. This represents a $2.20 annualized dividend and a yield of 0.78%. Cencora’s dividend payout ratio is presently 31.29%.

About Cencora

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.